Related by context. All words. (Click for frequent words.) 72 DNA methylation patterns 70 somatic mutations 70 molecular biomarkers 70 genomic alterations 70 beta1 integrin 69 chromosomal rearrangement 69 diagnostic biomarker 69 squamous cell lung cancer 69 kidney urologic 69 epithelial tumors 69 tumor subtypes 69 proliferative disorders 69 molecular subtypes 69 gene rearrangements 69 molecular determinants 69 PARP inhibition 69 FGFs 69 biologic pathways 69 primary cilia 69 etiologic factors 68 OGG1 68 genetic loci 68 mtDNA mutations 68 druggable targets 68 KRAS oncogene 68 BRAF gene 68 microRNA expression 68 anti angiogenic drugs 68 Colon polyps 68 sporadic ALS 68 p# mutations 68 biomarker identification 68 aneuploid cells 67 lymphoid tumors 67 chromosomal aberrations 67 monogenic 67 Genetic variations 67 Wnt signaling pathway 67 hereditary predisposition 67 oligodendrogliomas 67 etiologic 67 PTEN gene 67 chromosomal mutations 67 phenotypic expression 67 non coding RNA 67 neuropsychiatric diseases 67 antibody mediated 67 MIF protein 67 genetic aberrations 67 nodal metastasis 67 causative genes 67 inherited mutations 67 underlying pathophysiology 67 precursor lesions 67 seminomas 67 chromosome aberrations 67 osteosarcomas 67 motor neuron degeneration 67 mesothelial cells 67 cisplatin resistant 67 N glycan 67 HbF 67 putative biomarkers 67 murine models 67 mitochondrial mutations 67 distinct subtypes 67 Smac mimetics 67 biochemical abnormalities 66 Genetic variants 66 metabolomic profiles 66 diagnostic biomarkers 66 engineered RAP peptides 66 breast cancer subtypes 66 splice variants 66 metabolizing enzymes 66 ALK mutations 66 susceptibility loci 66 cellular pathways 66 amyloid plaque formation 66 pancreatic endocrine 66 NSCLC tumors 66 secretory pathway 66 de novo mutations 66 miRNA expression 66 myeloproliferative diseases 66 commonly mutated genes 66 serous ovarian cancer 66 Protein Kinase C 66 LRP5 66 ADAMTS# 66 Smac mimetic 66 splice junctions 66 histone deacetylases 66 MAPK pathway 66 pathogenic mechanisms 66 Genetic mutation 66 aneuploidies 66 missense mutations 66 GPC5 66 virulence genes 66 genomewide 66 stratifying patients 66 genetic variants associated 66 SSc 66 plexiform 66 genetic alterations 66 kinase inhibition 66 pre malignant lesions 66 K ras mutations 66 tumor suppressor protein 66 Epstein Barr Virus EBV 66 hypermethylated 66 neovascularisation 65 mutated K ras 65 aggregated Abeta 65 chromosomal anomalies 65 malignant prostate 65 MMP inhibitors 65 chromosome #p#.# 65 Glioblastoma multiforme GBM 65 hormone gastrin 65 metastatic lymph nodes 65 tumor subtype 65 arterial calcification 65 granzyme B 65 herpesviruses 65 hamartomas 65 predictive biomarkers 65 gastrointestinal stromal tumors GISTs 65 p#/CBP 65 mammary cells 65 carcinoid 65 mesenchymal cell 65 prognostic biomarkers 65 cathepsins 65 carcinoids 65 chromosomal regions 65 myelofibrosis polycythemia vera 65 chromosomal translocations 65 renal fibrosis 65 nonmelanoma skin cancers 65 ependymomas 65 ovarian pancreatic 65 Gliomas 65 Hutchinson Gilford progeria 65 promoter hypermethylation 65 eIF 4E 65 mitochondrial disorders 65 MYCN amplification 65 Basal cell 65 subclinical disease 65 NF kB pathway 65 sCJD 65 JAK2 enzyme 65 Sjögren syndrome 65 biologic pathway 65 Clusterin 65 ADPKD 65 GBA mutations 65 Medullary thyroid cancer 65 ALK inhibitors 65 PTPN# 65 EGFR pathway 65 breast cancer metastasis 65 mutated p# 65 methylation markers 65 LRRK2 gene 65 intracellular bacteria 65 mitochondrial toxicity 65 PI3K/mTOR 65 protein misfolding diseases 65 multiplex assay 65 prognostic markers 65 chromosome translocations 65 BRCA1 BRCA2 65 mTOR inhibitors 65 synovial cells 65 VHL gene 65 Genetic predisposition 65 familial pancreatic cancer 65 underlying molecular mechanisms 65 Relapsing remitting MS 65 medulloblastomas 65 Epstein Barr virus EBV 65 prion infection 65 PCNSL 65 multigenic 65 identify protein biomarkers 65 presymptomatic 65 mucinous 65 degenerative neurological diseases 65 epigenetic markers 65 lysosomal storage diseases 65 lymphoid cells 65 pleiotropic effects 65 HMGCR 65 genetic determinants 65 protein kinase inhibitors 65 radionuclide therapy 65 PI3K AKT 65 mammary stem cells 65 childhood leukemias 65 ZNF# 64 protein tyrosine phosphatases 64 liver metastasis 64 Leydig cell 64 GIST tumors 64 Shark cartilage 64 gene amplification 64 γδ T cells 64 protein tyrosine phosphatase 64 FGFR1 64 granulosa cell 64 BMPR2 64 CYT# potent vascular disrupting 64 molecular underpinnings 64 neuroendocrine cancers 64 tau protein tangles 64 plasma kallikrein 64 microsatellite instability 64 neuroblastomas 64 malignant nodules 64 RNAi therapeutic targeting 64 IGFBP2 64 histone deacetylase HDAC 64 skeletal metastases 64 radiolabeled antibodies 64 cytotoxic therapies 64 extramedullary 64 huntingtin gene 64 isotypes 64 systemic amyloidosis 64 pituitary adenomas 64 γ secretase 64 genomic rearrangements 64 myeloproliferative disorders 64 nonmelanoma 64 spontaneous mutations 64 leukaemias 64 CD# expression [001] 64 gastric cardia 64 BRAF protein 64 hematopoietic cancers 64 intracellular signaling pathways 64 immune modulating 64 invasive lobular 64 TMEM#B 64 TTR amyloidosis 64 ERK signaling 64 ependymoma 64 prostate cancer CaP 64 genetic polymorphisms 64 epithelial tissues 64 Genetic mutations 64 Skeletal muscle 64 renal carcinoma 64 gastric carcinomas 64 K ras gene 64 ductal adenocarcinoma 64 PKCi 64 Chronic pancreatitis 64 Squamous cell 64 malignant growths 64 mutated BRAF gene 64 breast endometrial 64 C1q 64 neuropilin 64 FGFR4 64 ABL1 64 mutated protein 64 CYP#D# gene 64 histological subtype 64 endostatin 64 cyclin E 64 chemoresistant 64 previously uncharacterized 64 NEDD9 64 clade B 64 WDR# 64 PTEN mutations 64 Gleevec resistant 64 malignant phenotype 64 UCRs 64 Akt3 64 modifier genes 64 lymphomas leukemias 64 highly vascularized 64 mycosis fungoides 64 endometrial cancers 64 endophenotypes 64 narcolepsy cataplexy 64 p# pathway 64 microvessels 64 CETP gene 64 synaptogenesis 64 cell signaling pathways 64 Darapladib 64 cyclic AMP cAMP 64 FGFR3 64 hyperplastic 64 Dr. Victor Velculescu 64 plexiform neurofibromas 64 cell nuclei 64 prostate carcinogenesis 64 carbohydrate antigens 64 gene locus 64 differential gene expression 64 EGFR mutant 64 activating mutation 64 adenocarcinomas 64 tumor metastases 64 HGPS 64 metaplasia 64 hypermethylation 64 serum antibodies 64 oncogenic mutations 64 infantile hemangioma 64 GISTs 64 neuroprotective therapies 64 gastric adenocarcinoma 64 cyclophilin D 64 microdeletion 64 genetic locus 64 microdeletions 64 apoptotic pathway 64 inhibit viral replication 64 pilocytic astrocytomas 64 malaria parasite Plasmodium falciparum 64 podocytes 64 pancreatic prostate 64 leukemias lymphomas 64 cAMP signaling 64 prognostic biomarker 64 candida infections 64 Malignant mesothelioma 64 susceptibility gene 64 S. maltophilia 64 nonviral 64 Acute lymphoblastic leukemia 64 vascular abnormalities 64 CaM kinase II 63 embryonal 63 metabolic dysfunction 63 GBM tumors 63 premalignant 63 microRNA biomarkers 63 hedgehog pathway 63 ciliopathies 63 p# activation 63 CDH1 63 Id1 63 B7 H3 63 FTLD 63 Squamous 63 microRNA molecules 63 myopathies 63 nonalcoholic steatohepatitis NASH 63 diabetic retinopathy DR 63 genetic susceptibilities 63 cardiotoxic effects 63 muscular dystrophies 63 FGFR2 63 malignant pancreatic 63 divide uncontrollably 63 N Myc 63 mechanistic insight 63 gastric carcinoma 63 epigenetic modification 63 MDSCs 63 exocrine glands 63 PIK3CA 63 Basal Cell 63 A3 adenosine receptor 63 leukaemic stem cells 63 sortilin 63 tNOX 63 costimulatory 63 Treg cell 63 insoluble plaques 63 mammary duct 63 tumoral 63 amyloid deposition 63 TGFBR1 * 6A 63 carbohydrate polymers 63 metastatic melanomas 63 telomere dysfunction 63 epigenetic regulation 63 oncogenic transformation 63 transgenic mouse models 63 germline mutation 63 molecularly targeted 63 histone deacetylase 63 circadian genes 63 intestinal polyps 63 TCF#L# gene 63 p# mutation 63 HER2 neu 63 sarcomatoid 63 microRNAs miRNAs 63 atherosclerotic lesions 63 oncogenesis 63 protein alpha synuclein 63 lung epithelium 63 potent antiproliferative 63 cardiometabolic disorders 63 molecular pathways 63 NPHP 63 Smad3 63 ADAM# 63 transgene expression 63 osteoblastic 63 validate biomarkers 63 Chronic lymphocytic leukemia 63 mTOR inhibition 63 STAT4 63 adipogenic 63 metastatic lesions 63 papillary renal cell carcinoma 63 HER2 positive cancers 63 metabolic enzymes 63 mutated genes 63 hematopoietic malignancies 63 abnormal proteins 63 fibrocytes 63 iPS derived 63 genomic instability 63 T#I [002] 63 retinoblastoma Rb 63 micro RNAs 63 DGAT1 63 inherited predisposition 63 IDH1 mutations 63 glial tumors 63 ovarian endometrial 63 tumorigenicity 63 beta amyloid peptide 63 obstructive coronary artery 63 prostate carcinomas 63 Peutz Jeghers syndrome 63 aerodigestive tract 63 DNA rearrangements 63 urothelial cancer 63 pleural mesothelioma 63 NKX#.# 63 noncancerous cells 63 lymphatic tissue 63 benign neoplasms 63 Six3 63 unresectable tumors 63 suppresses tumor 63 genetic underpinnings 63 small molecule activators 63 axonal degeneration 63 ANCA associated 63 pRb 63 conserved sequences 63 neuroblastoma tumors 63 radiosensitive 63 proliferative diseases 63 viral proteins 63 ovarian breast 63 lobular carcinomas 63 insulin secreting beta 63 fusion enhancers 63 Fibroblast Growth Factor Receptor 63 epithelial barrier 63 pathogenic mutations 63 signaling cascades 63 intracellular proteins 63 metastatic neuroendocrine tumors 63 MYH9 gene 63 TTR gene 63 potent inhibitors 63 protein misfolding 63 Polycythemia vera 63 APOL1 63 neuroinflammatory 63 Immunohistochemical analysis 63 aT cell 63 BRAF inhibitors 63 Fas ligand 63 progranulin mutations 63 protein p# 63 posttranslational modifications 63 neoplastic cells 63 PTEN protein 63 pathophysiological mechanisms 63 defective CFTR protein 63 serum biomarkers 63 PDGF receptor 63 CXCL5 63 fronto temporal dementia 63 glutamate signaling 63 mesotheliomas 63 leiomyoma 63 USP# 63 histone modifications 63 subclinical atherosclerosis 63 mammary cancers 63 neuropathologic 63 tissue fibrosis 63 epigenetic alterations 63 neoplastic 63 M2 subunit 63 chromatin structure 63 neurofibrillary 63 Kufs disease 63 diabetic kidney 63 biologies 63 antiproliferative effects 63 malaria parasite genome 63 JAK mutations 63 stem cells CSCs 63 fibrotic disease 63 tumor biopsies 63 noninvasive imaging 63 nerve degeneration 63 ABCB1 63 CXCR4 receptor 63 TPMT 63 Dr. Bezprozvanny 63 causal variants 63 chemosensitivity 63 Carcinoid tumors 63 peptide antigens 63 mutated Ras 63 CFTR gene 63 #ß HSD1 63 chronic inflammations 63 insertional mutagenesis 63 beta amyloid peptides 63 ERBB2 63 brain tumor glioblastoma multiforme 63 mutant proteins 63 HDACs 63 androgen receptor AR 63 STK# gene 63 pancreatic islet 63 HLA B# 63 amyloid beta plaques 63 Genetic profiling 63 Papillary 63 activated macrophages 63 causative mutations 63 Lafora disease 63 STK# [002] 63 #beta HSD1 62 endogenous ligands 62 Pseudomonas aeruginosa infections 62 alpha synuclein gene 62 germline mutations 62 ALK gene 62 Brodmann Area 62 MSH2 62 bone marrow mesenchymal stem 62 Fragile X gene 62 motor neuron diseases 62 NF kB signaling 62 Thyroid nodules 62 metabotropic glutamate receptors 62 MYH9 62 Genetic variation 62 BCR ABL mutations 62 MGUS 62 leiomyomas 62 BRAF mutation 62 intestinal epithelium 62 SGK1 62 SETDB1 62 prostate cancer PCa 62 malignant transformation 62 ACAT2 62 recurrent glioblastoma multiforme GBM 62 Upregulation 62 molecularly targeted therapies 62 etiological 62 PPARγ 62 epigenetic mechanisms 62 mitochondrial metabolism 62 amyloid deposits 62 Nedd4 62 FLT3 62 HLA DRB1 62 Malignant tumors 62 G6PD deficiency 62 tumor metastasis 62 glioblastoma tumor 62 leukotriene pathway 62 SMAD4 62 osteopontin OPN 62 antisense oligonucleotides 62 miRNA genes 62 proto oncogene 62 anticancer therapeutics 62 quasispecies 62 PLX MS 62 metabolomic 62 antisense inhibitors 62 serine protease 62 EGFR inhibition 62 Brugada syndrome 62 cervical breast 62 validating biomarkers 62 ANGPTL4 62 intracellular pathways 62 causal pathways 62 breast carcinomas 62 histocompatibility 62 DNA demethylation 62 neoplastic lesions 62 HG PIN 62 perilipin 62 Wwox 62 Squalamine 62 small molecule agonists 62 Li Fraumeni 62 Thyroid disorders 62 glutamic acid decarboxylase 62 astrocytomas 62 Autoimmune diseases 62 genomic deletions 62 Nanobodies ® 62 testicular germ cell 62 chromosomal instability 62 4E BP1 62 neovascular 62 epigenetic changes 62 TEL AML1 62 atypical hyperplasia 62 neuro degenerative disorders 62 anterior pituitary 62 inhibit angiogenesis 62 DHFR 62 ErbB1 62 miRs 62 glycosylated 62 nanocarrier 62 epithelial cancers 62 TGF b 62 nonvascular 62 tumor histology 62 miRNA biomarkers 62 SCN5A 62 fibrin deposition 62 gp# protein [002] 62 Karlseder 62 clefting 62 FTIs 62 Wnt pathway 62 potent cytotoxic 62 proteomic analysis 62 viral nucleic acids 62 TCF#L# 62 phosphorylated proteins 62 retroviral vectors 62 PI3K Akt 62 mRNA transcripts 62 neuron degeneration 62 pathological hallmark 62 bronchial epithelial cells 62 pathogenetic 62 lymphoid organs 62 melanocytic nevi 62 cirrhosis liver failure 62 CMV infections 62 M.tb 62 tumor antigen 62 epigenetically 62 idiopathic pulmonary 62 metabolic derangements 62 cardiac channelopathies 62 Affibody ® molecules 62 innate immune responses 62 genetic syndromes 62 Sezary syndrome 62 IGF IR 62 misfolded protein 62 glycolipids 62 Chlamydia trachomatis infection 62 Chronic myeloid leukemia 62 Ets2 62 biologic therapeutics 62 FOXO3a 62 aberrant activation 62 neovascular diseases 62 pleiotropic 62 renal cell carcinomas 62 PI3K inhibitors 62 hyperacute 62 lupus multiple sclerosis 62 mGluR5 antagonist 62 peritoneal carcinomatosis 62 diagnose coronary artery 62 senescent cells 62 intracellular signal transduction 62 incidentalomas 62 LRRK2 mutation 62 glycan 62 spontaneous regression 62 metalloprotease 62 antiangiogenic agents 62 NOTCH1 62 liver scarring 62 INF2 62 antisense RNA 62 VEGF receptor 62 immunotoxin 62 AT1R 62 pancreatic cysts 62 rxRNA TM compounds 62 preclinically 62 alpha synuclein protein 62 cardiolipin 62 genomewide association studies 62 achromatopsia 62 Endometrial cancer 62 deCODE BreastCancer 62 cellular prion protein 62 virotherapy 62 multisystem disease 62 genomic variants 62 Hurthle cell 62 neuronal dysfunction 62 tumor antigens 62 nonsmall cell lung cancer 62 TXNIP 62 allograft rejection 62 mutant BRAF 62 pelvic malignancies 62 CagA 62 gefitinib Iressa 62 neurite outgrowth 62 coding exons 62 spongiform encephalopathies 62 p tau 62 histological subtypes 62 proton MR spectroscopy 62 C. pneumoniae 62 transfusion syndrome 62 Htt 62 ATTR CM 62 lymphoid 62 HLA DQ2 62 oncomodulin 62 basal cell carcinoma BCC 62 benign moles 62 Zollinger Ellison Syndrome 62 PrPSc 62 colorectal carcinogenesis 62 transgenic rats 62 overactivation 62 hepatocellular carcinoma liver 62 susceptibility genes 62 genetic abnormalities 62 Neural stem cells 62 mechanistic insights 62 trophoblasts 62 progressive neurodegenerative disorder 62 neovascularization 62 MLL2 62 humanin 62 TP# mutation 62 inactivating mutations 62 transthyretin amyloidosis 62 breast pancreatic 62 monoclonal antibodies MAbs 62 EML4 ALK 62 MEF2A 62 filaggrin 62 c MET 62 prostate adenocarcinoma 62 Oxidative damage 62 Huntingtons disease 62 #q# deletion 62 TGFBR1 62 microglial cells 62 EGFR inhibitors 62 dyskeratosis congenita 62 hormonally sensitive 62 supratentorial 62 miRNA profiling 62 infected macrophages 62 neural cells 62 normal prion protein 62 adenomatous 62 Factor Receptor 62 epigenetic therapeutics 62 sphingolipid 62 HER2 expression 62 autoinflammatory diseases 62 pathophysiologic 62 metastatic tumors 62 serine threonine kinase 62 prognostic marker 62 Micro RNAs 62 CCR3 62 electrophysiological properties 62 etiologic agent 62 haematopoietic 62 axon guidance 62 bladder tumors 62 fatty acid biosynthesis 62 heritable disorders 62 LIS1 62 hypomethylation 62 metastatic bladder 62 histologic subtype 62 pancreatic adenocarcinoma 62 SMN protein 62 cardiac troponin T 62 carcinomatosis 62 CALHM1 62 cardiac fibroblasts 62 oxysterols 62 GPx 62 pre cancerous growths 62 C1 INH deficiency 62 colonic polyps 62 physiologic mechanisms 62 mTOR signaling pathway 62 Lymph node 62 humanized monoclonal antibodies 62 basal cell nevus syndrome 62 trophoblast cells 62 GATA4 62 infectious prion proteins 62 immunoglobulin genes 62 EGFR protein 62 cardioembolic stroke 62 tryptase 62 TLE3 62 cardiomyocyte 62 NPM1 mutation 62 Xenopus embryos 62 Fibroblasts 62 BRAF V#E mutation 62 C EBP alpha 62 5 hydroxymethylcytosine 62 miRNA molecules 62 amyloid proteins 62 Activating mutations 61 biochemical imbalances 61 Prion diseases 61 lesional 61 Francisella 61 autosomal recessive disease 61 invasive ductal 61 lung adenocarcinoma 61 eotaxin 61 Velculescu 61 lymphatic vasculature 61 M. pneumoniae 61 antiangiogenic therapy 61 Cyclin E 61 normal karyotype 61 mitogen activated protein kinases 61 cytostatic 61 colorectal carcinoma 61 eccrine 61 Li Fraumeni syndrome 61 bladder cancers 61 adrenocortical cancer 61 sarcosine 61 monogenic disorders 61 hyperparathyroidism 61 vitamin D receptors 61 tau aggregates 61 choroid 61 CHD5 61 hypervascular tumors 61 KLF4 61 osteoclast activity 61 gene deletions 61 malignant lymphomas 61 Hashimoto thyroiditis 61 MCF7 61 premalignant lesions 61 thoracic aortic aneurysm 61 gastro intestinal inflammation 61 respiratory viral infections 61 nanoprobes 61 Malignant glioma 61 MIF gene 61 neuronal nicotinic receptors NNRs 61 pharmacologic approaches 61 beta globin gene 61 p# Shc 61 precancerous cervical 61 commercialize deforolimus 61 bacterial virulence 61 activate p# 61 anemias 61 peroxisome 61 repolarization 61 mda 7 61 TRAIL induced apoptosis 61 KRAS mutation 61 imatinib Gleevec 61 TGF beta pathway 61 sirtuin activators 61 Autoimmune disorders 61 P#X# 61 stellate cells 61 tumor hypoxia 61 acinar cells 61 EBV infection 61 serotonin receptor 61 MTHFR 61 melanocytic 61 synthetic lethality 61 metabolic abnormality 61 Trichomonas vaginalis 61 neurofibromas 61 oncoprotein 61 GATA3 61 tenascin C 61 ductal breast cancer 61 Cdc7 61 anti angiogenic therapy 61 protein isoforms 61 Alessandro Riva 61 miR #a [002] 61 druggable target 61 MTHFD1L gene 61 multifactorial disease 61 effector function 61 cranial irradiation 61 PPARg 61 beta defensins 61 nodular melanoma 61 histopathologic findings 61 acute leukemias 61 HCV replication 61 BCR ABL protein 61 leukemic stem cell 61 somatostatin receptors 61 BCL6 gene 61 pharmacologic intervention 61 malignant tissue 61 MAPCs 61 MEK inhibitors 61 p# alpha [002] 61 thymidylate synthase 61 β amyloid 61 mucins 61 abnormal glucose metabolism 61 leukemic stem cells 61 mammographically 61 uPAR 61 amyloid formation 61 posttranslational modification 61 Cathepsin B 61 hepatocellular carcinomas 61 imatinib resistance 61 transthyretin 61 Diabetic nephropathy 61 deCODE AF TM 61 LPA gene 61 antisense therapies 61 pleomorphic 61 metabolic abnormalities 61 genetic heterogeneity 61 COX enzymes 61 IRS1 61 suppressor gene 61 Prognostic factors 61 p# MAPK 61 SOD1 gene 61 transgenic mouse model 61 microglial 61 Aromatase 61 haematologic 61 neurofibroma 61 MEK ERK 61 biopsychosocial 61 peptidic 61 methylation patterns 61 pulmonary metastasis 61 gastric cancers 61 multigene 61 Candida infection 61 previously undescribed 61 PCA3 gene 61 HBeAg negative 61 upregulating 61 HepDirect prodrug 61 TH# cells 61 genetic biomarkers 61 MAP kinase 61 noncoding RNAs 61 p# biomarker 61 adenomatous polyps 61 myelomas 61 SOD2 gene 61 enterotypes 61 pretreatment serum 61 micronuclei 61 granzyme 61 Glioblastoma multiforme